0001437749-23-010517.txt : 20230418
0001437749-23-010517.hdr.sgml : 20230418
20230418113547
ACCESSION NUMBER: 0001437749-23-010517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230415
FILED AS OF DATE: 20230418
DATE AS OF CHANGE: 20230418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pirozzi Gianluca
CENTRAL INDEX KEY: 0001809894
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37411
FILM NUMBER: 23825943
MAIL ADDRESS:
STREET 1: C/O TIMBER PHARMACEUTICALS, INC.
STREET 2: 900 E. HAMITON AVENUE, SUITE 100
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001504167
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593843182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: (917) 697-3130
MAIL ADDRESS:
STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharmX Corp
DATE OF NAME CHANGE: 20140304
FORMER COMPANY:
FORMER CONFORMED NAME: THOMPSON DESIGNS INC
DATE OF NAME CHANGE: 20101022
4
1
rdgdoc.xml
PIROZZI FORM 4
X0407
4
2023-04-15
0001504167
Timber Pharmaceuticals, Inc.
TMBR
0001809894
Pirozzi Gianluca
C/O TIMBER PHARMACEUTICALS, INC.
3 MOUNTAINVIEW RD, SUITE 100
WARREN
NJ
07059
1
0
Common Stock, par value $0.001 per share
2023-04-15
4
A
0
4100
0
A
6100
D
Stock Option (right to buy)
1.66
2023-04-15
4
A
0
4100
0
A
2032-04-15
Common Stock
4100
4100
D
On April 15, 2023, the Reporting Person was granted 4,100 restricted stock units, which will be settled in shares of common stock, par value $0.001. The restricted stock units vest in 12 equal monthly installments beginning on May 15, 2023, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.
25% of the options vest on April 15, 2024, and the remaining shares will become exercisable in 36 equal monthly installments beginning on May 15, 2024, as long as the Reporting Person remains in continuous service with Timber Pharmaceuticals, Inc. through each vesting date.
/s/ Joseph Lucchese, Power of Attorney
2023-04-18